News

Previously, laboratories could only detect the drug through urine using liquid chromatography-mass spectrometry-mass spectrometry (LC/MS/MS) technology. Tapentadol, approved by the FDA in late 2008, is considered a narcotic

MorphoSys said that the new patent (JP 4436457) covers the production and design of an antibody library based on phage display. Currently, the company is prosecuting more than

Primary data from the Navigator (Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research) trial, initiated in 2001, were presented at the American College of Cardiology Annual Meeting

According to GSK, Eltrombopag is indicated for adult chronic ITP splenectomised patients who are refractory (have not responded) to other treatments, such as corticosteroids and immunoglobulins. Eltrombopag may

A once-daily dose of oral betrixaban that was given to patients with non-valvular atrial fibrillation or atrial flutter and at least one risk factor for stroke showed reduced

Under terms of the agreement, Takeda granted Ranbaxy a non-exclusive royalty free license to its US patents covering Actos. Ranbaxy has certainty in the launch of its generic

Reportedly, numerous published studies showed the benefits of GLA supplementation, including anti-inflammatory effects, and improved skin health and appearance. A recent study by Schirmer and Phinney found that

Medtronic said the E-Pooled analysis, which included five-year data from the Endeavor I (E-I), Endeavor II (E-II), E-II Continued Access (CA), and Endeavor III (E-III) clinical studies, and

As per the terms of the merger agreement, Manhattan, upon the closing, issued 7.06 million shares of its common stock to Ariston stockholders and debt holders (which represents